Variables | TB treatment outcomea | cOR (95% CI) | P value | aOR (95% CI) | P value | ||
---|---|---|---|---|---|---|---|
Unsuccessful n (%) | Successful n (%) | ||||||
Sex | Male | 45 (5.7) | 344 (94.3) | 1 | Â | 1 | Â |
Female | 29 (8.1) | 328 (91.9) | 1.5(0.92.4) | 0.12 | 1.5(0.9–2.5) | 0.10 | |
Age group (in years) | 0–14 | 8 (11.6) | 61(88.4) | 1 |  | 1 |  |
15–24 | 17 (7.2) | 220(92.) | 1.7(0.7–4) | 0.24 | 1.8(0.73–4.46) | 0.20 | |
25–34 | 11 (6.4) | 160(93.) | 1.9(0.7–5) | 0.19 | 2(0.77–5.4) | 0.15 | |
35–44 | 18 (16.5) | 91 (83.5) | 0.66(0.27–1.6) | 0.37 | 0.73(0.29–1.8) | 0.50 | |
45–54 | 7 (9.2) | 60 (90.8) | 1.12(0.38–3.3) | 0.8 | 1.18(0.4–3.5) | 0.76 | |
55–64 | 6 (8.3) | 36 (91.7) | 0.78(0.25–2.45) | 0.68 | 0.8(0.25–2.5) | 0.70 | |
≥ 65 | 7 (13.7) | 44 (86.3) | 0.8(0.28–2.4) | 0.72 | 0.86(0.3–2.6) | 0.78 | |
Type of TB | PTB+ | 18 (9.5) | 171(90.5) | 1 | Â | 1 | Â |
PTB- | 29 (10.5) | 247(89.5) | 0.89(0.48–1.66) | 0.70 | 1.04(0.5–2) | 0.89 | |
EPTB | 27 (9.6) | 254(90.4) | 0.99(0.5–1.8) | 0.98 | 1.04(0.5–2) | 0.89 | |
TB registration status | New | 62 (10.1) | 550(89.9) | 1 | Â | 1 | Â |
Relapse | 4 (8.2) | 45 (91.8) | 1.3(0.44–3.6) | 0.66 | 1.48(0.5–4.4) | 0.47 | |
Treatment after Failure | 1(5.9) | 16 (94.1) | 1.8(0.23–31.8) | 0.57 | 1.6(0.2–12.7) | 0.65 | |
Transfer in | 6 (9.7) | 56 (90.3) | 1.05(0.44–2.5) | 0.9 | 0.93(0.37–3) | 0.87 | |
Other | 1 (16.7) | 5 (83.3) | 0.56(0.06–4.9) | 0.6 | 0.37(0.04–3.3) | 0.37 | |
HIV status | Positive | 21 (11.9) | 155(88.1) | 1 | Â | 1 | Â |
Negative | 50 (9.2) | 494(90.8) | 1.33(0.78–2.3) | 0.30 | 1.37(0.76–2.4) | 0.23 | |
Unknon | 3 (11.5) | 23 (88.5) | 1.03(0.28–3.76) | 0.95 | 1.13(0.3–4.2) | 0.5 |